Clinical Trial Details
— Status: Recruiting
Administrative data
| NCT number |
NCT02989298 |
| Other study ID # |
PD registry |
| Secondary ID |
|
| Status |
Recruiting |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
December 2013 |
| Est. completion date |
December 2026 |
Study information
| Verified date |
October 2020 |
| Source |
Sun Yat-sen University |
| Contact |
Xueqing Yu, M.D. & Ph.D. |
| Phone |
8620-87766335 |
| Email |
yuxq[@]mail.sysu.edu.cn |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
Brief Summary: The investigators are registering all PD patients at recruited hospitals and
developing a PD database in China. Patients will be followed up every 3 months, and both
baseline and follow-up information will be collected and input into the registration system.
The patient survival, technical survival, peritonitis rate, longitudinal changes of residual
renal function and peritoneum function, and quality of life for PD patients, etc, will be
compared using the PD database.
Description:
Detailed Description: The investigators are registering all end stage renal disease (ESRD)
patients receiving peritoneal dialysis (PD) treatment, and developing a PD database in China.
Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking,
drinking, and education, etc), clinical characteristics (primary cause of ESRD, dialysis
prescription, patient's condition and lab measurements of serum, urine, and dialysate), drug
information, complications and scores of quality of life at the baseline will be collected.
Patients will be followed up every 3 months. Demographic and clinical characteristics,
complications, drug information of patients will be collected at each visit. The patients'
clinical outcomes, such as mortality (including all-cause mortality and cardiovascular
disease mortality), technical survival, kidney transplantation, transfer to hemodialysis,
hospitalization, occurrence of peritonitis, etc. were also followed up till the end of the
study. The data of patient survival, technical survival, peritonitis rate, hospitalization
rate, clinical lab parameters, longitudinal changes of residual renal function and peritoneum
function, peritonitis rate, hospitalization rate, clinical lab parameters and quality of life
for PD patients will be analyzed using the PD database.
